involved in restriction. HR4 to HR7 consisted of human Trim5␣ has a modular design with a series of distinct Trim5␣ with decreasing lengths of rhesus sequences motifs. These include the RING motif, a B-Box, and a substituted within the SPRY domain, whereas RH4 to coiled-coil domain, which together form the tripartite RH7 formed a reciprocal series where the rhesus Trim5␣ RBCC domain characterizing Trim proteins, as well as was substituted with human SPRY sequences. As expected, all the chimeras could restrict N-MLV, but not
restriction was absent when the rhesus sequences after
We next sought to identify individual residues between amino acids 322 and 374 in the SPRY domain residue 374 were replaced with human ones from HR5 to HR7. This suggested that the region determining that affected restriction. Between the human and rhesus sequence, there was a difference of seven amino acids, specificity for HIV-1 restriction was between amino acids 322 to 374 of the rhesus Trim5␣. RH4, which does two contiguous, the others scattered throughout the region. In addition, a stretch of six residues starting from not restrict HIV-1, lacked the rhesus sequence in this region. When the rhesus sequence was included in the amino acid 335 in the human sequence was replaced by 8 different residues in the rhesus sequence. The resichimera RH5, restriction of HIV-1 was restored, confirming the requirement of this region in HIV-1 recognition dues at these positions in the human Trim5␣ were replaced with the corresponding residues from rhesus and restriction. The requirements for MLV restriction were found to be somewhat different from that of HIV-1. monkey by site-directed mutagenesis. The mutants were then assayed for restriction of HIV-1 and MLV (Fig-HR4 to HR7 
